WEST SACRAMENTO, CA -- (MARKET WIRE) -- February 14, 2007 -- Lipomics Technologies, Inc., a privately held company that specializes in the analysis of lipid metabolites, announced today that it has entered into an agreement with Isis Pharmaceuticals, Inc. to provide lipid-focused support of preclinical and clinical trial testing for various compounds to treat metabolic disease.
